Natalizumab
Products Natalizumab is commercially available as a concentrate for the preparation of an infusion solution (Tysabri). It has been approved in many countries since 2007. Structure and properties Natalizumab is a recombinant and humanized IgG4ϰ antibody produced in mouse cells that binds to α4-integrins. Effects Natalizumab (ATC L04AA23) has selective immunosuppressive properties. The effects are … Natalizumab